Literature DB >> 26308770

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma.

S W Erickson1, O W Stephens2, S S Chavan2, E Tian2, J Epstein2, B Barlogie2, C J Heuck2, A J Vangsted3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26308770      PMCID： PMC5330385          DOI： 10.1038/leu.2015.238

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.

Authors:  Fenghuang Zhan; Johanna Hardin; Bob Kordsmeier; Klaus Bumm; Mingzhong Zheng; Erming Tian; Ralph Sanderson; Yang Yang; Carla Wilson; Maurizio Zangari; Elias Anaissie; Christopher Morris; Firas Muwalla; Frits van Rhee; Athanasios Fassas; John Crowley; Guido Tricot; Bart Barlogie; John Shaughnessy
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

2.  Prediction of cytogenetic abnormalities with gene expression profiles.

Authors:  Yiming Zhou; Qing Zhang; Owen Stephens; Christoph J Heuck; Erming Tian; Jeffrey R Sawyer; Marie-Astrid Cartron-Mizeracki; Pingping Qu; Jason Keller; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

3.  In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.

Authors:  Erming Tian; Jeffrey R Sawyer; Christoph J Heuck; Qing Zhang; Frits van Rhee; Bart Barlogie; Joshua Epstein
Journal:  Genes Chromosomes Cancer       Date:  2014-03-17       Impact factor: 5.006

4.  Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Authors:  Niels Weinhold; David C Johnson; Andrew C Rawstron; Asta Försti; Chi Doughty; Jayaram Vijayakrishnan; Peter Broderick; Nasrin B Dahir; Dil B Begum; Fay J Hosking; Kwee Yong; Brian A Walker; Per Hoffmann; Thomas W Mühleisen; Christian Langer; Elisabeth Dörner; Karl-Heinz Jöckel; Lewin Eisele; Markus M Nöthen; Dirk Hose; Faith E Davies; Hartmut Goldschmidt; Gareth J Morgan; Kari Hemminki; Richard S Houlston
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

5.  Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma.

Authors:  Stephen W Erickson; Vinay R Raj; Owen W Stephens; Ishwori Dhakal; Shweta S Chavan; Naveen Sanathkumar; Elizabeth Ann Coleman; Jeannette Y Lee; Julia A Goodwin; Senu Apewokin; Daohong Zhou; Joshua Epstein; Christoph J Heuck; Annette J Vangsted
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 6.  Cancer genetics and genomics of human FOX family genes.

Authors:  Masuko Katoh; Maki Igarashi; Hirokazu Fukuda; Hitoshi Nakagama; Masaru Katoh
Journal:  Cancer Lett       Date:  2012-09-27       Impact factor: 8.679

7.  A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.

Authors:  Christina M Annunziata; Lidia Hernandez; R Eric Davis; Adriana Zingone; Laurence Lamy; Lloyd T Lam; Elaine M Hurt; Arthur L Shaffer; W Michael Kuehl; Louis M Staudt
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

8.  Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity.

Authors:  Michael Rouse; Antoine Younès; Josephine M Egan
Journal:  J Endocrinol       Date:  2014-11       Impact factor: 4.286

9.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

10.  Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.

Authors:  Peter Broderick; Daniel Chubb; David C Johnson; Niels Weinhold; Asta Försti; Amy Lloyd; Bianca Olver; Yussanne Ma; Sara E Dobbins; Brian A Walker; Faith E Davies; Walter A Gregory; J Anthony Childs; Fiona M Ross; Graham H Jackson; Kai Neben; Anna Jauch; Per Hoffmann; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Ian P Tomlinson; Hartmut Goldschmidt; Kari Hemminki; Gareth J Morgan; Richard S Houlston
Journal:  Nat Genet       Date:  2011-11-27       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.